CW-270033, a Novel Pyrrolidinyl-thio Carbapenem, Has Potent Antimicrobial Activity in Vitro and in Vivo
-
- Kim JongMyeung
- Department of Microbiology, Kyungpook National University
-
- Ha Jong Ryul
- Central Research Institute, ChoongWae Pharmaceutical Corp.
-
- Oh Se Woong
- Central Research Institute, ChoongWae Pharmaceutical Corp.
-
- Kim Hong Gi
- Central Research Institute, ChoongWae Pharmaceutical Corp.
-
- Lee Jin-Man
- Department of Herb & Food Science, Kyongbuk College of Science
-
- Lee Dong Gun
- Department of Microbiology, Kyungpook National University
-
- Lee Sang-Han
- Department of Food Science & Technology, Kyungpook National University
-
- Kim Jong Guk
- Department of Microbiology, Kyungpook National University
この論文をさがす
抄録
CW-270033, an injectable carbapenem, is a novel, synthesized pyrrolidinyl-thio carbapenem. In the present study, the in-vitro and in-vivo antibacterial activities of CW-270033 against wild-type strains and clinical isolates were compared with those of imipenem and meropenem. CW-270033 was more active than imipenem against Gram-negative (Escherichia coli and Pseudomonas aeruginosa) clinical isolates, but was slightly less active than meropenem. Against the Gram-positive clinical isolates methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE), CW-270033 was slightly more active than meropenem, but was less active than imipenem. CW-270033 displayed potent in-vivo activity against E. coli ATCC 25922, P. aeruginosa ATCC 27853, and S. aureus SMITH in the mouse systemic infection model; the efficacy of CW-270033 in this model was 2—7 fold higher than that of meropenem. This activity was comparable to the in-vitro activity of CW-270033. An intravenous injection of CW-270033 showed that the half-life of CW-270033 in serum in mice was about 20 min, which was about two times that of meropenem. CW-270033 was also found to be resistant to hydrolysis by the mouse renal dehydropeptidase I (DHP-I) enzyme.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 30 (3), 575-579, 2007
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679601053312
-
- NII論文ID
- 110006239206
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 8658340
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可